Litcius/Paper detail

ESMO expert consensus statements on the management of EGFR mutant non-small-cell lung cancer

Antonio Passaro, Natasha B. Leighl, Fiona Blackhall, Sanjay Popat, Keith M. Kerr, Myung‐Ju Ahn, Maria E. Arcila, Óscar Arrieta, David Planchard, Filippo de Marinis, Anne‐Marie C. Dingemans, Rafał Dziadziuszko, Corinne Faivre‐Finn, Jill Feldman, Enriqueta Felip, Giuseppe Curigliano, Roy S. Herbst, Pasi A. Jänne, Thomas John, Tetsuya Mitsudomi, Tony Mok, Nicola Normanno, Luis Paz‐Ares, Suresh S. Ramalingam, Lecia V. Sequist, Johan Vansteenkiste, Ignacio I. Wistuba, Juergen Wolf, Yi‐Long Wu, Sihai Yang⧫, James Chih‐Hsin Yang, Yasushi Yatabe, George Pentheroudakis, Solange Peters

2022Annals of Oncology191 citationsDOIOpen Access PDF

Topics & Concepts

MedicineGuidelineVotingConsensus conferenceClinical trialMultidisciplinary approachLung cancerFamily medicinePanel discussionMEDLINEOncologyMedical physicsIntensive care medicinePathologyInternal medicinePoliticsSocial scienceAdvertisingLawBusinessSociologyPolitical scienceLung Cancer Treatments and MutationsLung Cancer Diagnosis and TreatmentGastric Cancer Management and Outcomes
ESMO expert consensus statements on the management of EGFR mutant non-small-cell lung cancer | Litcius